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Abstract: Percutaneous interventions of the coronary and peripheral vessels have historically 
been performed using a femoral artery approach. There has been increasing recognition of post-
procedural bleeding complications and its impact on short- and long-term mortality. Because of 
its now recognized safety, the transradial approach has recently emerged as a preferred method 
compared to the transfemoral approach. The limitations associated with the distance from the 
puncture site to the lesion location are being addressed as new tools are developed for the endo-
vascular treatment of peripheral arterial disease. In this review, we discuss the many facets of 
the transradial approach to lower extremity endovascular interventions, highlighting its safety 
and efficacy. Approaches to special populations including individuals with prior surgical bypass, 
Leriche’s syndrome, and those committed to chronic anticoagulation are also reviewed.
Keywords: peripheral arterial disease, endovascular interventions, transradial interventions, 
aorto-iliac angioplasty
Introduction
Percutaneous interventions of the coronary and peripheral vessels have historically 
been performed using a femoral artery approach. Alternative access sites, including 
the brachial and axillary arteries, have been employed in clinical scenarios where groin 
access is contraindicated. Nevertheless, these approaches have been associated with 
a relatively high risk of vascular and nerve complications. Furthermore, cannulation 
of these arteries has the potential for thrombotic occlusion which may put the entire 
distal limb at risk. Recently, post-procedural bleeding complications with a femoral 
approach have raised safety concerns, due to their contribution to both short- and 
long-term mortality. As such, the transradial approach (TRA) has gained significant 
interest, and a growing body of evidence from the coronary literature has demonstrated 
this method to be safer than the transfemoral approach (TFA), while still maintaining 
efficacy.1,2 Despite this, the TRA technique has not become mainstream in the United 
States, as a large report from the National Cardiovascular Data Registry has shown a 
usage rate for coronary procedures of only 1.32% between 2004–2007.3
In recent years, there has been a surge of interest in percutaneous peripheral vascular 
interventions. The poly-vascular nature of atherosclerosis that is frequently present in 
the individual who manifests with peripheral arterial disease (PAD), makes   surgical 
repair options riskier and often precludes the use of such an aggressive approach. 
As such, there has been a dramatic development of endovascular tools and techniques. 
It follows that the use of percutaneous modalities coupled with safer access-site 
  strategies, may offer the higher-risk PAD patient the greatest safety   margin. Based upon Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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the extensive safety data for the use of the TRA for coronary 
angiography and interventions, we have extrapolated this 
technique to interventions of the aorto-iliac arterial system 
and have published our safety and efficacy data.4,5 In this 
review, we discuss the many facets of the TRA and highlight 
the feasibility of this technique for endovascular interventions 
of the lower extremities.
Anatomy
Whether for coronary or peripheral interventions, it is 
mandatory that the radial operator be well-versed with 
normal radial artery anatomy and its anatomical variants. 
The radial artery in most people starts at the bifurcation of 
the brachial artery just below the bend of the elbow. It then 
passes along the radial side of the forearm to the wrist and 
terminates by passing between the two heads of the first 
interosseous dorsalis and into the palm. At this level, it 
loops across the metacarpal bones towards the ulnar side of 
the hand, uniting with the deep palmar branch of the ulnar 
artery.6 There is extensive communication between the ulnar 
and radial branches that maintain blood flow to the hand in 
the event of radial occlusion.
Knowledge of anatomical variants is essential as it allows 
for anticipation of problems as they may arise during the 
course of the procedure and facilitates appropriate measures 
to overcome difficult anatomy. Two large reviews have 
demonstrated that anatomical variants, including tortuosities, 
stenoses, hypoplasias, and radioulnar loops occur in up to 
23% of transradial catheterizations.7,8 These abnormalities 
could lead to significantly reduced puncture and procedural 
success rates.
It is also important to discern the caliber of the radial 
artery, as this factor has implications regarding equipment 
selection. An abnormally small caliber of the radial artery 
may be due to spasm, hypoplasia, or atherosclerosis. In the 
latter case, the radial artery is not protected from atheroscle-
rotic disease. Histopathologic studies examining the radial 
artery in patients with coronary artery disease have shown 
that up to 7% have severe plaque burden and approximately 
21% have medial calcification.9,10 These diseased arteries are 
more likely to be prone to spasm.
In our experience, we have encountered more spasm in 
patients with smaller diameter radial arteries. Given that 
the long sheaths used during peripheral interventions must 
traverse the entire length of the upper extremity, particular 
attention must be devoted to the administration of appropriate 
spasmolytic cocktails and sedation. This is of even greater 
importance at the end of the case during sheath removal, since 
the prolonged exposure of the radial artery to the large-sized 
sheath, may lead to significant spasm.
Anthropometric data, including arm and torso length, are 
important considerations in the TRA as there are limitations 
to equipment use in taller individuals. Currently, the longest 
available sheath is 110 cm, and the longest shaft length for 
the available stents is 135 cm. In taller patients, accessing 
the left radial artery as opposed to the right radial artery 
eliminates about 10–12 cm in length due to the proximity of 
the left subclavian artery to the descending aorta.
It is equally important to identify the presence of certain 
risk factors that may alter the tortuosity and the course of 
the radial artery, including the presence of long-standing 
hypertension and older age. However, aside from making 
sheath delivery difficult, once positioned, these variations 
do not cause further problems in carrying out peripheral 
interventions as they do for coronary procedures.
Technical considerations
The routine approach to the suprainguinal intervention starts 
with gaining access from the left radial artery. This has the 
advantage of traversing a shorter distance to the descending 
aorta and not crossing the aortic arch and cerebral vessels. 
The left subclavian artery most often directs the angio-
grapher towards the descending aorta, so we usually begin 
the procedure with a 125 cm multipurpose catheter and an 
angle-tipped hydrophilic coated 0.035″ wire. Occasionally, 
an internal mammary shape catheter may be required to 
negotiate the descending aorta due to a type III aortic arch. 
Regardless of the wire used, it is mandatory that its passage 
is carefully followed with fluoroscopy to its destination in 
the lower abdominal aorta. Severe complications can result 
from “blind” advancement of the wire into tributaries of the 
thoracic or abdominal aorta. We recommend that in most 
cases, angiography of the aorto-iliac system begins with a 
pigtail “power” injection of the lower abdominal aorta (typi-
cally 20 milliliters over one second in the antero-posterior 
projection). This initial scout film may help define any aortic 
aneurysms, collateral vessels, and the presence of ostial 
disease of the common iliac arteries. This initial view may 
be forgone only in the presence of renal insufficiency with 
the backup of excellent non-invasive imaging. Selective 
angiography of the entire lower extremity is then performed 
with the 5 Fr 125 cm multipurpose catheter.
Current stent and balloon platforms of all major manu-
facturers can be safely accommodated within 6 Fr diameter 
sheaths. We most commonly use a 6 Fr 110 cm-long sheath 
(Cook Medical, Bloomington, IN) that is easily positioned Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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at the proximal common iliac artery, or just at the distal 
aorta in case of ostial iliac disease. From this point on, all 
interventions are performed in the similar fashion as from 
the femoral approach.
The current available equipment only allows for iliac 
and proximal superficial femoral artery (SFA) interventions, 
due to limitations regarding the shaft length.   Nevertheless, a 
recent study showed the potential for effective SFA   balloon 
angioplasty in a small cohort of patients with   in-stent 
  restenosis.11 This was possible due to the recent availabil-
ity of 180 cm balloon shaft lengths (Medtronic Invatec, 
  Bethlehem, PA). However, the current introducer sheaths 
are a maximum of 110 cm, and the longest shaft length for 
stent platforms is still limited to 135 cm (Abbott Vascular, 
Santa Clara, CA). To complete interventions throughout the 
entire SFA, stent shafts of at least 160–170 cm are required. 
In spite of the current limitations, the potential benefits of the 
TRA outlined above should justify development of specific 
devices designed for this purpose.
Safety
The fundamental reason for the tremendous interest in the 
TRA compared to any other arterial access sites derives not 
only from its favorable anatomical distinctiveness, but also its 
unrivaled safety profile. Most of this safety data stems from 
the coronary literature, as repeated studies comparing the 
TRA to the TFA have demonstrated a significant reduction 
in bleeding complications, further translating into reduced 
short and long-term mortality. A review of all transradial 
coronary interventions from the National Cardiovascular 
Data Registry performed between 2004–2007 showed sig-
nificantly lower bleeding risks [odds ratio 0.42 (0.31–0.56)], 
even after multivariable adjustment.3 Another recent review 
of 32,822 patients in British Columbia undergoing cardiac 
procedures noted that access site bleeding complications 
necessitating blood transfusions conferred a significantly 
increased 30-day and 1-year mortality [odds ratio 4.01 (3.08 
to 5.22) and 3.58 (2.94 to 4.36), respectively].12 The use of a 
radial technique halved this rate of blood transfusion.
Until recently, there have been no studies comparing the 
use of the TRA to other arterial access sites for peripheral 
angioplasty. In the only study published, at the time of this 
writing, that compared the TRA and TFA in aorto-iliac inter-
ventions, our group demonstrated a comparable safety profile 
between the two approaches.5 At our institution, we collected 
prospective data on 68 subjects with claudication and criti-
cal limb ischemia, who underwent aorto-iliac interventions 
between June 2007 and June 2009. Twenty-seven patients 
had 33 lesions treated via the TRA, while 41 patients had 
47 lesions treated via the TFA. There were no major access 
site complications (defined as either a hematocrit drop by 
at least 10% or surgery/packed red blood cell transfusion 
requirement to correct bleeding) in either group.   Thirty-day 
major adverse events, including myocardial infarction, 
stroke, death, target-vessel revascularization, or amputation, 
were also not present in either group. Only in the TRA group 
were no minor access-site complications present, defined as 
persistent bleeding requiring use of additional compressive 
devices or the development of local hematoma. The TFA 
group showed a 7.3% rate of such complications. These find-
ings are consistent with the growing body of evidence from 
the coronary literature that the TRA is safer than the TFA.
There has been some concern regarding radiation expo-
sure to both the patient and operator, during transradial inter-
ventions, as studies from the coronary literature have shown 
mixed results. Furthermore, there is a perception of higher 
radiation exposure via the left compared to the right TRA. 
In interpreting this data, one must be careful to distinguish 
total fluoroscopy time from total procedural time, as the latter 
may prove to be more time-consuming for the TRA in terms 
of dedicated access time and set-up. One coronary study 
illustrated that the total procedural time was significantly 
longer with the TRA compared to the TFA (18.1 vs 15.0 min, 
P = 0.009), whereas the fluoroscopy time was not different 
(5.6 ± 5.9 vs 4.7 ± 3.9, P = 0.47).13 In our peripheral study, 
there was no difference between the TRA and TFA interven-
tions in terms of total fluoroscopy time (TRA: 30.4 min vs 
TFA: 26.6 min, P = 0.60), despite the majority of cases being 
performed from the left TRA. Another study even showed 
a significant reduction in fluoroscopy and procedural times 
using the left TRA for coronary catheterizations.14 Therefore, 
concerns about radiation exposure with the left TRA should 
not dissuade operators from the radial approach for aortoiliac 
interventions.
Efficacy
The advantages to the TRA in aorto-iliac angioplasty and 
stenting extend even beyond its safety to its efficacy. Other 
than a description of the use of the TRA for lower   extremity 
interventions,15 comparison data to other access sites in terms 
of efficacy endpoints are limited to only two studies. In a 
small cohort of 12 subjects with SFA in-stent restenosis, 
one report demonstrated successful balloon angioplasty in 
all cases using the TRA and marked improvements in walk-
ing distance at follow-up.11 The second study, presented 
by our group, looked at the outcomes from 80 aorto-iliac Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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  interventions.5 Both the TRA and TFA groups showed 
  similar mean baseline Rutherford category (2.9 vs 2.6, 
respectively) and pre-intervention ankle-brachial index 
(0.64 vs 0.67, respectively). However, lesion parameters 
differed, as the TRA group was characterized by a three-
fold higher presence of total occlusions (27.3% vs 8.5%, 
P = 0.03) and a greater baseline diameter stenosis (89.2% vs 
82.3%, P = 0.003). Despite this inequality in lesion types, 
there was no difference in mean procedural time (TRA: 
97.9 min vs TFA: 83.4 min, P = 0.08) or contrast volume 
requirement (TRA: 238.7 mL vs TFA: 213.1 mL, P = 0.35). 
Interestingly, during the course of the study, the procedural 
time became shorter by an average of 25 min within the 
TRA group (112.3 min to 87.6 min, P = 0.07), suggesting a 
positive learning curve. In addition, the primary and second-
ary procedural success rates were similar between the TRA 
and TFA groups (87.9% vs 97.8%, P = 0.15 and 93.9% vs 
100%, P = 0.17, respectively). Post-intervention hemody-
namics, as measured by ankle-brachial index, showed similar 
degrees of improvement (TRA: 0.64 to 0.77 and TFA: 0.67 
to 0.85, P = 0.77).
Our experience with TRA in aorto-iliac interventions 
clearly demonstrated that despite the worse case-mix that 
was present in the TRA group, this technique can be as 
successful as the TFA. Furthermore, radial access can be 
a viable option even for more complex peripheral lesion 
types, as the prevalence of TASCII C and D lesions in our 
study approached 40%. There are two additional issues 
that concern beginner radial operators. The first has to do 
with the anticipated need for larger balloon and stent sizes 
requiring bigger delivery sheaths, given the larger vessel 
diameters of the iliac arteries. The second has to do with the 
longer distance from the puncture site to the target lesion. 
As shown in our study, interventions in the TRA cohort were 
not limited to smaller angioplasty devices; in fact the mean 
stent diameter deployed for the TRA cohort was 9.30 mm 
compared to 9.33 mm for the TFA subjects. Further, all stent 
platforms were successfully delivered through 6 Fr sheaths. 
Finally, the distance to the target lesion was never an indi-
cation to abort the TRA and resort to the TFA in order to 
complete the procedure.
Special populations
Perhaps endovascular interventions for select anatomical 
and clinical presentations are better served when approached 
using the TRA. These particular subgroups include individu-
als with prior surgical bypass, Leriche’s syndrome, and those 
committed to chronic anticoagulation.
Surgical bypass
Individuals who have undergone previous surgical revas-
cularization, particularly aorto-bifemoral bypass, pose 
a unique challenge in that the two bypass conduits usu-
ally form an acute angle from their anastamotic take-off 
Figure 1 Transradial approach to a left proximal SFA total occlusion in a patient with a history of aorto-bifemoral bypass. A) Distal anastamosis site of bypass conduit to CFA 
and total occlusion of SFA at its ostium. B) Crosser CTO recanalization catheter (Flowcardia) successfully passing through proximal total occlusion. C) Balloon angioplasty 
of proximal SFA. D) Final result at the end of procedure.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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from the distal aorta. The nature of this reconstruction 
precludes a   contralateral retrograde femoral approach to 
common femoral artery (CFA) or proximal SFA lesions. 
Meanwhile, the narrow angle formed by the bypass limbs 
is easily traversed from above via the radial approach, 
lending even greater support. In Figure 1, we illustrate a 
proximal SFA chronic total occlusion in a patient with a 
history of aorto-bifemoral bypass that was successfully 
treated via the TRA.
Leriche’s syndrome
Atherosclerotic occlusive disease of the infrarenal abdo-
minal aorta and iliac vessels is seldom limited to the 
suprainguinal territory. In fact, most surgical series have 
reported that up to two-thirds of individuals presenting with 
aorto-iliac occlusive disease have infrainguinal disease 
as well.16 Accessing the CFA in such an individual with 
extensive disease makes them more susceptible to local 
vascular complications, including dissection, subintimal 
guidewire passage, and vessel perforation. Furthermore, 
compressing the CFA after the procedure in the presence of 
occlusive disease may lead to ischemia or even   thrombosis. 
In Figure 2, we illustrate a patient who presented with 
Leriche’s syndrome that was successfully recanalized via 
the TRA.
Certain types of occlusive disease may present 
relatively acutely requiring urgent attention. The recom-
mended therapies for individuals with acute limb ischemia 
categorized as Rutherford class I or IIa include catheter-
directed thrombolysis. The TRA in such patients would be 
the safest access strategy as it avoids all of the potential 
catastrophic complications that could occur from a TFA 
approach.
Anticoagulation
Many individuals require chronic anticoagulation with 
warfarin. A prerequisite to contemplating a lower extremity 
intervention in such a patient is either bridging therapy with 
shorter-acting agents or reversal of anti-coagulation with 
vitamin K or by wash-out. Depending upon the severity of 
the indication for chronic anticoagulation, this is not an easy 
task, with its attendant clinical risks during transition and 
time costs. Given the safety of the TRA in terms of access-
site bleeding, there is essentially no need to discontinue 
Figure 2 Transradial approach to Leriche’s syndrome. A) Aortogram showing distal aorta total occlusion. B) Balloon angioplasty of left common iliac artery (CiA) following 
successful wire crossing. C) Catheter-directed thrombolysis of left CiA. D) Left CIA opacification following overnight infusion of tPA. E) Kissing balloon inflation of bilateral 
CiA. F) Successful restoration of inflow.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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  anticoagulation. In one prospective series, 50 consecutive 
patients on chronic   anticoagulation underwent percutaneous 
coronary interventions via radial access without reversing 
anticoagulation (mean INR of 2.2 ± 0.6). There were no 
complications during the hospital stay for the entire series. 
There was only one minor bleed, eight days after the proce-
dure, unrelated to the access site.17
Additional benefits
There have been numerous studies from the coronary litera-
ture demonstrating cost savings using a radial approach com-
pared to other access sites, but this benefit can be extended 
to peripheral interventions. The cost reduction derives from 
the use of fewer resources and shorter hospital stays, partly 
as a result of decreased bleeding complications that obvi-
ate the need for additional, expensive tests (ie, computed 
tomography scans, ultrasounds, phlebotomy). One recent 
analysis comparing the TRA to the TFA in cardiac cath-
eterizations noted that the total procedural cost, including 
access devices, contrast material volume, catheters, closure 
devices, and recovery, was significantly reduced using the 
former approach.18 In terms of length of stay, a metanalysis 
showed that the use of the TRA for various patient popula-
tions, including elective and emergent coronary interven-
tions, resulted in a significant reduction in the hospital stay 
by 0.4 days (P = 0.0001).19 In our own series of aorto-iliac 
interventions, the time to discharge was significantly shorter 
for the TRA group compared to the TFA group (14.4 hr vs 
20.9 hr, P = 0.003).
Future developments
The TRA to infrainguinal interventions is still limited by 
the lack of adequate equipment. As the endovascular field 
advances, an emphasis must be placed on upgrading the 
currently available tools. Long marker wires to precisely 
measure the distance from the entry point to the iliac system 
are needed, and a larger variety of sheath and wire lengths 
should be made available. Balloon, stents, and atherectomy 
devices that can reach the popliteal and proximal tibial 
vessels, at the very least, should be developed. Rescue 
catheters have to be long enough to extend into the dorsal 
and plantar arches. Furthermore, there should be an empha-
sis on downsizing the caliber of these devices, in order to 
allow all interventions to be performed through 5 Fr or 6 Fr 
sheaths. As a final point, training programs that allow for 
proficiency in performing transradial interventions need to 
be expanded.
Conclusion
In the final analysis, the transradial approach to peripheral 
vascular interventions offers numerous advantages, beyond 
the well-established lower risk of post-procedural bleeding. 
We strongly support the use of the radial artery as the access 
site for interventions to the aorto-iliac vascular bed. More 
advanced support catheters, larger balloons, and improved 
stent selection are needed before this field moves on into the 
superficial femoral artery interventions.
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